Principle Wealth Partners LLC Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Principle Wealth Partners LLC lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,705 shares of the financial services provider’s stock after selling 322 shares during the period. Principle Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $754,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. SPC Financial Inc. grew its stake in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management grew its stake in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares during the last quarter. Chicago Partners Investment Group LLC grew its stake in iShares Biotechnology ETF by 2.5% in the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after purchasing an additional 94 shares during the last quarter. Capital Investment Advisors LLC grew its stake in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after purchasing an additional 99 shares during the last quarter. Finally, Magnus Financial Group LLC grew its stake in iShares Biotechnology ETF by 0.8% in the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock valued at $1,714,000 after purchasing an additional 104 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $134.24 on Wednesday. The business has a 50-day simple moving average of $135.99 and a two-hundred day simple moving average of $141.17. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.